AGP Executive Report
Last update: 2 hours agoEmerging Infection: WHO is investigating the first reported human case of Shamonda virus, after an immunocompromised older man in eastern France died following severe encephalitis. The virus usually affects livestock, and officials say information on its effects in people is limited. Medicine Safety: The European Medicines Agency is reviewing depression and anxiety drug Deanxit after reports of serious movement, memory and thinking problems, some persisting after treatment stopped. Cancer Care: ImmunityBio says the first European patients have received Anktiva with BCG for certain bladder cancers. Its conditional EU approval also covers Liechtenstein. Health Cover: Liechtenstein-based Squarelife supports Genki’s updated international health insurance, which now offers cover from one month and expands preventive and dental benefits.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.